ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 44 announcements

Share price
₹768.80
Market cap
₹12,100 Cr
Revenue (annual)
₹4,359 Cr
Net profit (annual)
₹255.2 Cr
P/E (TTM)
33.3×Sector 43.8×
Promoter holding
75.26%+0.00% QoQ
FII holding
4.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:14 IST NSE
Financial Results

Akums Drugs & Pharmaceuticals Q2 FY27 Results: Net Profit ₹114.6 Cr, Up 168.4% YoY

Akums Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹1,342 Cr (+31.9% YoY) and net profit of ₹114.6 Cr (+168.4% YoY) for Q2 FY27.

Key figure
Net profit ₹114.6 Cr · +168.4% YoY
15:47 IST NSE
Financial Results

Akums Drugs & Pharmaceuticals Q1 FY27 Results: Net Profit ₹101 Cr, Up 56.1% YoY

Akums Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹1,167 Cr (+13.9% YoY) and net profit of ₹101 Cr (+56.1% YoY) for Q1 FY27.

Key figure
Net profit ₹101 Cr · +56.1% YoY